Cargando…

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations

This case–control study of 25 cases with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with vancomycin minimum inhibitory concentration (MIC) ≥ 2 µg/mL and 391 controls (MIC < 2 µg/mL) characterized the clinical characteristics, treatments, and outcomes associated with elevated va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mills, Alexandra G., Dupper, Amy C., Chacko, Kieran I., Alburquerque, Bremy, Nadkarni, Devika, Berbel Caban, Ana, Fox, Lindsey, Gitman, Melissa R., Obla, Ajay, van Bakel, Harm, Altman, Deena R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Concise Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173282/ https://www.ncbi.nlm.nih.gov/pubmed/37179762 http://dx.doi.org/10.1017/ash.2023.163

Ejemplares similares

261. A Single-Center Case Series of Methicillin-Resistant S. aureus Bacteremia with Elevated Minimal Inhibitory Concentrations to Vancomycin
por: Mills, Alexandra, et al.
Publicado: (2020)

Everybody nose: molecular and clinical characteristics of nasal colonization during active methicillin-resistant Staphylococcus aureus bloodstream infection
por: Reategui Schwarz, Erika, et al.
Publicado: (2022)

552. Within-Host Evaluation of Colonization During Active Methicillin-Resistant S. aureus Bacteremia
por: Berbel Caban, Ana B, et al.
Publicado: (2019)

191. When Staph Is Not Solo: Polymicrobial Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Escalona, Angelica, et al.
Publicado: (2023)

Staphylococcus aureus Bacteremia in Patients Infected With COVID-19: A Case Series
por: Cusumano, Jaclyn A, et al.
Publicado: (2020)

Modified methicillin-resistant Staphylococcus aureus detected in neonatal intensive care patients
por: Gitman, Melissa R, et al.
Publicado: (2021)

2129. When Is Methicillin-resistant Staphylococcus aureus not Methicillin-resistant Staphylococcus aureus?
por: Gitman, Melissa R, et al.
Publicado: (2019)

Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus faecium Bacteremia
por: Chacko, Kieran I., et al.
Publicado: (2018)

Blurred Molecular Epidemiological Lines Between the Two Dominant Methicillin-Resistant Staphylococcus aureus Clones
por: Dupper, Amy C, et al.
Publicado: (2019)

PathoSPOT genomic epidemiology reveals under-the-radar nosocomial outbreaks
por: Berbel Caban, Ana, et al.
Publicado: (2020)

2561. Using Whole Genome Sequencing to Assess the Emergence of Antibiotic Resistance During Treatment of Enterococcus faecium and Enterococcus faecalis Bacteremia at Mount Sinai Hospital
por: Chacko, Kieran, et al.
Publicado: (2018)

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aguado, Jose Maria, et al.
Publicado: (2011)

Genomic confirmation of vancomycin-resistant Enterococcus transmission from deceased donor to liver transplant recipient
por: Bashir, Ali, et al.
Publicado: (2017)

Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
por: Gregory, Eric R., et al.
Publicado: (2022)

The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia
por: Fu, Chien-Fang, et al.
Publicado: (2018)

Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial
por: Kalimuddin, Shirin, et al.
Publicado: (2014)

Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis
por: Samura, Masaru, et al.
Publicado: (2022)

Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
por: Zahlanie, Yorgo, et al.
Publicado: (2021)

Demographic Characteristics of Adults with IgG Antibodies to Prior Symptomatic SARS-CoV-2 Infection
por: Mansour, Mayce, et al.
Publicado: (2021)

Hospital-onset bacteremia and fungemia: examining healthcare-associated infections prevention through a wider lens
por: Schrank, Gregory M., et al.
Publicado: (2023)

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
por: Schweizer, Marin L, et al.
Publicado: (2011)

Clinical Significance of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Schwaber, Mitchell J., et al.
Publicado: (2003)

Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2017)

Spread of a methicillin-resistant Staphylococcus aureus ST80 strain in the community of the northern Netherlands
por: Stam-Bolink, E. M., et al.
Publicado: (2007)

Evaluation of the impact of nasal colonization with methicillin-resistant Staphylococcus aureus on left ventricular assist device infections
por: Koscal, Lauren J., et al.
Publicado: (2022)

Outcomes among patients with Staphylococcus aureus bacteremia enrolled in a postdischarge outpatient parenteral antibiotic therapy program at an academic medical center
por: Theodore, Deborah A., et al.
Publicado: (2022)

The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia
por: Honda, Hitoshi, et al.
Publicado: (2011)

Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia
por: Seah, Jonathan, et al.
Publicado: (2013)

1062. Daptomycin/Ceftaroline in Combination vs. Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Fox, Matthew, et al.
Publicado: (2018)

Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus
por: Komoto, Atsushi, et al.
Publicado: (2018)

187. Vancomycin Plus Ceftaroline Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Kufel, Wesley D, et al.
Publicado: (2021)

1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Caniff, Kaylee E, et al.
Publicado: (2023)

A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study
por: Kalimuddin, Shirin, et al.
Publicado: (2018)

Accessory Gene Regulator Polymorphism and Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus
por: Park, Min-Jeong, et al.
Publicado: (2015)

Clinical utility of methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction (PCR) assays beyond respiratory infections
por: Noeldner, Haley M., et al.
Publicado: (2022)

Carriage of vancomycin-resistant Enterococcus faecium in infants following an outbreak in the neonatal intensive care unit: time to clearance of carriage and use of molecular methods to detect colonization
por: Schechner, Vered, et al.
Publicado: (2023)

Septic Thrombophlebitis with Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia and de Novo Resistance to Vancomycin and Daptomycin
por: Koton, Yael, et al.
Publicado: (2017)

Evolution of Multi-Resistance to Vancomycin, Daptomycin, and Linezolid in Methicillin-Resistant Staphylococcus aureus Causing Persistent Bacteremia
por: Chen, Chih-Jung, et al.
Publicado: (2020)

276. Comparison of Ceftaroline in Combination with Either Vancomycin or Daptomycin for the Treatment of Methicillin-resistant Staphylococcus aureus Bacteremia
por: Welch, Stephanie N, et al.
Publicado: (2020)

Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients?
por: Aminzadeh, Zohreh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_87viruegelp16chpo6bmvj8gmq